{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/53468"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/53468","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Characterization of pneumolysin activity across vaccine and non-vaccine serotypes of Streptococcus pneumoniae","abstract":"Streptococcus pneumoniae is a bacteria that causes pneumococcal infection in humans. Pneumococcal infection may lead to pneumonia, otitis media, and sinusitis. The pneumolysin protein was historically identified as the principal virulent factor of S. pneumoniae. Pneumolysin is primarily responsible for lysis of human Red Blood Cells (RBCs) once infection has taken place within the human body. This lysis of human RBCs further promotes the severity of pneumococcal infection. Our research intended to ascertain whether there were any differences found in pneumolysin activity among serotypes of S. pneumoniae, both vaccine and non-vaccine serotypes, and if such differences accounted for severity of pneumococcal infection across serotypes. We employed the use of a human RBC hemoglobin protein assay, liquid-culture growth medium, and a positive control serotype of S. pneumoniae (19F), to examine differences amongst the several serotypes (19F, 3, 15B, 23A, 23B, 11, 22F, 21, and 35B) with respect to different cell fractions (‘Lysate Pellet’, ‘Whole Bacteria’, ‘Primary Supernatant’, and ‘Secondary Supernatant’). Following analysis of our data, we concluded that there were largely no significant differences in the amounts of pneumolysin activity across the multiple serotypes of S. pneumoniae that we tested. However, our results revealed that the S. pneumoniae serotype 15B was the only serotype among serotypes tested had any viable growth following twenty-four hours of liquid-culture growth. This finding poses questions for further investigations surrounding the pathogenicity of S. pneumoniae and the mechanism behind the pneumolysin activity and the bacterial survival.","abstract_html":"Streptococcus pneumoniae is a bacteria that causes pneumococcal infection in humans. Pneumococcal infection may lead to pneumonia, otitis media, and sinusitis. The pneumolysin protein was historically identified as the principal virulent factor of S. pneumoniae. Pneumolysin is primarily responsible for lysis of human Red Blood Cells (RBCs) once infection has taken place within the human body. This lysis of human RBCs further promotes the severity of pneumococcal infection. Our research intended to ascertain whether there were any differences found in pneumolysin activity among serotypes of S. pneumoniae, both vaccine and non-vaccine serotypes, and if such differences accounted for severity of pneumococcal infection across serotypes. We employed the use of a human RBC hemoglobin protein assay, liquid-culture growth medium, and a positive control serotype of S. pneumoniae (19F), to examine differences amongst the several serotypes (19F, 3, 15B, 23A, 23B, 11, 22F, 21, and 35B) with respect to different cell fractions (‘Lysate Pellet’, ‘Whole Bacteria’, ‘Primary Supernatant’, and ‘Secondary Supernatant’). Following analysis of our data, we concluded that there were largely no significant differences in the amounts of pneumolysin activity across the multiple serotypes of S. pneumoniae that we tested. However, our results revealed that the S. pneumoniae serotype 15B was the only serotype among serotypes tested had any viable growth following twenty-four hours of liquid-culture growth. This finding poses questions for further investigations surrounding the pathogenicity of S. pneumoniae and the mechanism behind the pneumolysin activity and the bacterial survival.","abstract_has_math":false,"creators":["Sanabria Amaro, Joseph"],"institution":"Boston University","degree_name":"Master of Science","degree_level":"masters","degree_discipline":"Medical Sciences","degree_department":null,"school":null,"contributors":[],"advisors":["Pelton, Stephen I","Shaik-Dasthagirisaheb, Yazdani"],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T19:44:18Z","subjects":["Biology"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[{"key":"dc:identifier.orcid","label":"ORCID","values":["0009-0001-5737-9280"],"render_values":[{"text":"0009-0001-5737-9280","href":"https://orcid.org/0009-0001-5737-9280","code":true}]}]},"links":{"outbound_url":"https://hdl.handle.net/2144/53468","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/53468","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F53468","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Pelton, Stephen I","Shaik-Dasthagirisaheb, Yazdani"]},{"key":"dc:creator","label":"Author","values":["Sanabria Amaro, Joseph"]},{"key":"dc:identifier.orcid","label":"ORCID","values":["0009-0001-5737-9280"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-09-17T17:27:50Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2026-09-17T17:27:50Z"]},{"key":"dc:date.issued","label":"Date","values":["2026"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2026-09-17T16:15:26Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Medical Sciences"]},{"key":"thesis:degree_level","label":"Degree Level","values":["masters"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Biology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/53468"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["2026"]},{"key":"dc:description.abstract","label":"Abstract","values":["Streptococcus pneumoniae is a bacteria that causes pneumococcal infection in humans. Pneumococcal infection may lead to pneumonia, otitis media, and sinusitis. The pneumolysin protein was historically identified as the principal virulent factor of S. pneumoniae. Pneumolysin is primarily responsible for lysis of human Red Blood Cells (RBCs) once infection has taken place within the human body. This lysis of human RBCs further promotes the severity of pneumococcal infection. Our research intended to ascertain whether there were any differences found in pneumolysin activity among serotypes of S. pneumoniae, both vaccine and non-vaccine serotypes, and if such differences accounted for severity of pneumococcal infection across serotypes. We employed the use of a human RBC hemoglobin protein assay, liquid-culture growth medium, and a positive control serotype of S. pneumoniae (19F), to examine differences amongst the several serotypes (19F, 3, 15B, 23A, 23B, 11, 22F, 21, and 35B) with respect to different cell fractions (‘Lysate Pellet’, ‘Whole Bacteria’, ‘Primary Supernatant’, and ‘Secondary Supernatant’). Following analysis of our data, we concluded that there were largely no significant differences in the amounts of pneumolysin activity across the multiple serotypes of S. pneumoniae that we tested. However, our results revealed that the S. pneumoniae serotype 15B was the only serotype among serotypes tested had any viable growth following twenty-four hours of liquid-culture growth. This finding poses questions for further investigations surrounding the pathogenicity of S. pneumoniae and the mechanism behind the pneumolysin activity and the bacterial survival."]},{"key":"dc:title","label":"Title","values":["Characterization of pneumolysin activity across vaccine and non-vaccine serotypes of Streptococcus pneumoniae"]}]}],"canonical_facts":{"dc:contributor.advisor":["Pelton, Stephen I","Shaik-Dasthagirisaheb, Yazdani"],"dc:creator":["Sanabria Amaro, Joseph"],"dc:date.accessioned":["2026-09-17T17:27:50Z"],"dc:date.available":["2026-09-17T17:27:50Z"],"dc:date.issued":["2026"],"dc:date.updated":["2026-09-17T16:15:26Z"],"dc:description":["2026"],"dc:description.abstract":["Streptococcus pneumoniae is a bacteria that causes pneumococcal infection in humans. Pneumococcal infection may lead to pneumonia, otitis media, and sinusitis. The pneumolysin protein was historically identified as the principal virulent factor of S. pneumoniae. Pneumolysin is primarily responsible for lysis of human Red Blood Cells (RBCs) once infection has taken place within the human body. This lysis of human RBCs further promotes the severity of pneumococcal infection. Our research intended to ascertain whether there were any differences found in pneumolysin activity among serotypes of S. pneumoniae, both vaccine and non-vaccine serotypes, and if such differences accounted for severity of pneumococcal infection across serotypes. We employed the use of a human RBC hemoglobin protein assay, liquid-culture growth medium, and a positive control serotype of S. pneumoniae (19F), to examine differences amongst the several serotypes (19F, 3, 15B, 23A, 23B, 11, 22F, 21, and 35B) with respect to different cell fractions (‘Lysate Pellet’, ‘Whole Bacteria’, ‘Primary Supernatant’, and ‘Secondary Supernatant’). Following analysis of our data, we concluded that there were largely no significant differences in the amounts of pneumolysin activity across the multiple serotypes of S. pneumoniae that we tested. However, our results revealed that the S. pneumoniae serotype 15B was the only serotype among serotypes tested had any viable growth following twenty-four hours of liquid-culture growth. This finding poses questions for further investigations surrounding the pathogenicity of S. pneumoniae and the mechanism behind the pneumolysin activity and the bacterial survival."],"dc:identifier.orcid":["0009-0001-5737-9280"],"dc:identifier.uri":["https://hdl.handle.net/2144/53468"],"dc:language.iso":["en_US"],"dc:subject":["Biology"],"dc:title":["Characterization of pneumolysin activity across vaccine and non-vaccine serotypes of Streptococcus pneumoniae"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Medical Sciences"],"thesis:degree_level":["masters"],"thesis:degree_name":["Master of Science"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-18T19:44:18Z"}